There has been a flood of interest about the experimental serum used to treat the American Ebola patients, so the Centers for Disease Control and Prevention just released their answers to common questions that have been popping up. For example:
They basically outline that this treatment is still very much at the pre-human phase of clinical trial development, and so it's a long way off from reaching patients. You can read more here.
This effort is part of CDC's response to public interest and anxiety over Ebola. Time magazine reported that there has been a flurry of worried callers to the agency over Ebola in recent weeks. "We've triaged those calls and about half-dozen or so resulted in specimen coming to CDC for testing and all have been negative for Ebola," CDC spokesman Tom Skinner told Time.
We have a request
Most news outlets make their money through advertising or subscriptions. But when it comes to what we’re trying to do at Vox, there are a couple of issues with relying on ads and subscriptions to keep the lights on:
1. Advertising dollars go up and down with the economy. We often only know a few months out what our advertising revenue will be, which makes it hard to plan.
2. We’re not in the subscriptions business. Vox is here to help everyone understand the complex issues shaping the world — we believe that’s an important part of building a more equal society. And we can’t do that if we have a paywall.
It’s important that we have several ways we make money, and that’s why we ask readers for help keeping Vox free. Our goal today is for 47 Vox readers to pledge an annual financial gift to Vox to help us keep our work free for everyone. Will you become one of them?
Yes, I'll give $120/year
Yes, I'll give $120/year
We accept credit card, Apple Pay, and
Google Pay. You can also contribute via
:format(webp)/cdn.vox-cdn.com/uploads/chorus_image/image/36576352/453210018.0.jpg)
